JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266486

Human EIF2AK1 (Heme-regulated inhibitor) knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

EIF2AK1 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 2 bp insertion in exon 2. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
2 Images
Sanger Sequencing - Human EIF2AK1 (Heme-regulated inhibitor) knockout HEK-293T cell line (AB266486)
  • Sanger seq

Supplier Data

Sanger Sequencing - Human EIF2AK1 (Heme-regulated inhibitor) knockout HEK-293T cell line (AB266486)

Allele-2 : 2 bp insertion in exon 2.

Sanger Sequencing - Human EIF2AK1 (Heme-regulated inhibitor) knockout HEK-293T cell line (AB266486)
  • Sanger seq

Supplier Data

Sanger Sequencing - Human EIF2AK1 (Heme-regulated inhibitor) knockout HEK-293T cell line (AB266486)

Allele-1 : 1 bp insertion in exon2

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 2 bp insertion in exon 2

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Sanger seq": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Although we aim to provide customers with a homozygous clone, feasibility will be dependent on the biology of the protein. Should only heterozygous edits be achieved, you will be notified of the outcome and be asked to confirm whether the cell line is acceptable. All clones will be accompanied with DNA sequencing data, and the mutation description.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266486-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266486-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266486 Human EIF2AK1 (Heme-regulated inhibitor) knockout HEK-293T cell line", "number":"AB266486-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266486-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266486 Human EIF2AK1 (Heme-regulated inhibitor) knockout HEK-293T cell line", "number":"AB266486-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
EIF2AK1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Heme-regulated inhibitor (HRI) also known as eIF2α kinase 1 plays an important role in controlling protein synthesis in response to heme availability. It weighs approximately 80 kDa and is primarily expressed in erythroid cells in the bone marrow where hemoglobin synthesis occurs. HRI works as a sensor of heme levels and regulates the translation initiation process by phosphorylating the eukaryotic translation initiation factor 2 alpha (eIF2α) which reduces general protein synthesis under heme-deficient conditions.
Biological function summary

Heme-regulated inhibitor functions as an important part of the cellular stress response. It is not a standalone entity and often forms part of larger signaling networks as it interacts with eIF2α. In addition to its role in erythroid cells HRI responds to various stressors including oxidative stress and heat shock by modulating protein production which contributes to cellular adaptation mechanisms. Its activity helps maintain homeostasis by reducing protein synthesis when cells face adverse conditions.

Pathways

HRI significantly influences the integrated stress response (ISR) pathway and iron metabolism. HRI's activation through phosphorylation of eIF2α links it to related proteins such as activating transcription factor 4 (ATF4) which assists in adaptive gene expression changes under stress conditions. This action highlights HRI's involvement in pathways that regulate translation under various stress conditions maintaining proper cellular function and response to changes in environmental and internal conditions.

HRI has a pivotal involvement in conditions like anemia and beta-thalassemia. An imbalance in HRI activity can lead to inadequate or excessive protein synthesis contributing to disease states. It connects to alpha-globin and beta-globin proteins through its regulation of hemoglobin synthesis in erythroid cells. In iron deficiency anemia HRI activation prevents excess protein synthesis that would otherwise require unavailable heme while its dysfunction might exacerbate issues in beta-thalassemia by impairing stress response and erythropoiesis.

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com